Moleculent vs Seevix
Moleculent vs Seevix, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moleculent is on 61/100 and Seevix on 52/100.
Where each one leads
Moleculent
- our overall score: 61/100 against 52/100
- agent readiness: 47/100 against 41/100
- domain rating: 36/100 against 14/100
- headcount: 64 against 13
- funding raised: $46.0M against $11.0M
Seevix
- LinkedIn following: 1,908 against 345
At a glance
| Measure | Moleculent | Seevix |
|---|---|---|
| What it is | Mapping cell-cell communication at scale in human tissue. | Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications. |
| Category | Biotech, Life Sciences, Genomics, Drug Discovery | Biotech, Life Sciences, Material Sciences, Synthetic Biology |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2019 | 2014 |
| Headquarters | Stockholm, Sweden | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Moleculent | Seevix |
|---|---|---|
| Employees | 64 | 13 |
| Headcount growthLast 12 months | Not published | -59.4% |
| Total funding | $46.0M | $11.0M |
| Latest round | Series B | Seed |
| LinkedIn followers | 345 | 1,908 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moleculent | Seevix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 52/100 |
| Traction | 56/100 | 47/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 37/100 | 23/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moleculent | Seevix |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Tailwind CSS | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4 |
| Support stack | HubSpot | Not detected |
Moleculent vs Seevix: common questions
Which is better, Moleculent or Seevix?
On our 0-100 score Moleculent rates higher (61/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Moleculent and Seevix compare on the numbers?
Moleculent leads on our overall score (61/100 against 52/100), agent readiness (47/100 against 41/100), domain rating (36/100 against 14/100), headcount (64 against 13), funding raised ($46.0M against $11.0M). Seevix leads on LinkedIn following (1,908 against 345).
Read the full Moleculent review and pricing or the Seevix review and pricing. You can also browse other Moleculent alternatives we track.